Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
暂无分享,去创建一个
Sheyla Ortiz de García | Gilberto Pinto Pinto | Pedro A García-Encina | Rubén I Irusta Mata | Sheyla Ortiz de García | Gilberto Pinto Pinto | P. García‐Encina
[1] M. Haight,et al. Expert Stakeholders’ Views on the Management of Human Pharmaceuticals in the Environment , 2006, Environmental management.
[2] J. Brausch,et al. A review of personal care products in the aquatic environment: environmental concentrations and toxicity. , 2011, Chemosphere.
[3] A. Bodour,et al. Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. , 2010, Environmental pollution.
[4] Robert S. Boethling,et al. Predicting ready biodegradability in the Japanese ministry of international trade and industry test , 2000 .
[5] R. Hannah,et al. Environmental risk assessment of paroxetine. , 2004, Environmental science & technology.
[6] Diana S Aga,et al. Pharmaceutical metabolites in the environment: Analytical challenges and ecological risks , 2009, Environmental toxicology and chemistry.
[7] Christa S. McArdell,et al. Consumption and occurrence , 2006 .
[8] H. Budzinski,et al. New challenges in environmental analytical chemistry: Identification of toxic compounds in complex mixtures , 2011 .
[9] T. Ternes,et al. Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.
[10] S. Snyder,et al. Toxicological relevance of pharmaceuticals in drinking water. , 2010, Environmental science & technology.
[11] R. Brain,et al. Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones. , 2004, Toxicology.
[12] Klaus Kümmerer,et al. The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges. , 2009, Journal of environmental management.
[13] Robert S. Boethling,et al. Group contribution method for predicting probability and rate of aerobic biodegradation. , 1994, Environmental science & technology.
[14] Beate I. Escher,et al. Recent advances in environmental risk assessment of transformation products. , 2011, Environmental science & technology.
[15] J. Garric,et al. Progestagens for human use, exposure and hazard assessment for the aquatic environment. , 2009, Environmental pollution.
[16] Frank A. P. C. Gobas,et al. A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessments for organic chemicals in aquatic organisms , 2006 .
[17] C. Delerue-Matos,et al. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. , 2010, Journal of hazardous materials.
[18] A. Al-Ahmad,et al. Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water , 2010, Environmental science and pollution research international.
[19] D. A. Barry,et al. Methodology to account for uncertainties and tradeoffs in pharmaceutical environmental hazard assessment. , 2012, Journal of environmental management.
[20] Y. Perrodin,et al. Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents. , 2012, Journal of environmental management.
[21] Ettore Zuccato,et al. Strategic Survey of Therapeutic Drugs in the Rivers Po and Lambro in Northern Italy , 2003 .
[22] Marion Letzel,et al. Fate of the antibiotic sulfamethoxazole and its two major human metabolites in a water sediment test. , 2009, Environmental science & technology.
[23] N Voulvoulis,et al. Pharmaceuticals in the aquatic environment--a comparison of risk assessment strategies. , 2004, Chemosphere.
[24] Robert S. Boethling,et al. Predictive model for aerobic biodegradability developed from a file of evaluated biodegradation data , 1992 .
[25] Arun Kumar,et al. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. , 2010, The Science of the total environment.
[26] F. Gagné,et al. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. , 2006, Ecotoxicology and environmental safety.
[27] K. Fent,et al. Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.
[28] Rainer Brüggemann,et al. A Comparison of Partial Order Technique with Three Methods of Multi-Criteria Analysis for Ranking of Chemical Substances , 2002, J. Chem. Inf. Comput. Sci..
[29] G. Streck. Chemical and biological analysis of estrogenic, progestagenic and androgenic steroids in the environment , 2009 .
[30] E. Cooper,et al. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. , 2008, The Science of the total environment.
[31] John D. Walker,et al. Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. , 2003, Environmental health perspectives.
[32] Despo Fatta-Kassinos,et al. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research , 2011, Analytical and bioanalytical chemistry.
[33] Hans Sanderson,et al. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. , 2004, Regulatory toxicology and pharmacology : RTP.
[34] D. Barceló,et al. Endocrine disruptors in sewage treatment plants, receiving river waters, and sediments: Integration of chemical analysis and biological effects on feral carp , 2002, Environmental toxicology and chemistry.
[35] S. Meriç,et al. Occurrence patterns of pharmaceuticals in water and wastewater environments , 2007, Analytical and bioanalytical chemistry.
[36] M. Gavrilescu,et al. Pharmaceuticals, Personal Care Products and Endocrine Disrupting Agents in the Environment – A Review , 2009 .
[37] S. McGrath,et al. Low biodegradability of fluoxetine HCl, diazepam and their human metabolites in sewage sludge-amended soil , 2008 .
[38] D. Barceló,et al. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. , 2010, Environment international.
[39] M Verwei,et al. Development of a QSAR for worst case estimates of acute toxicity of chemically reactive compounds. , 2007, Toxicology letters.
[40] T. Heberer. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.
[41] Manuela Pavan,et al. Review of QSAR Models for Ready Biodegradation , 2006 .
[42] Rainer Brüggemann,et al. Ranking of pharmaceuticals detected in the environment: aggregation and weighting procedures. , 2008, Combinatorial chemistry & high throughput screening.
[43] Robert Boethling,et al. Chemical structure-based predictive model for methanogenic anaerobic biodegradation potential. , 2007, Environmental toxicology and chemistry.
[44] B. Brooks,et al. Active Pharmaceutical Ingredients andAquatic Organisms , 2011 .
[45] P. G. Encina,et al. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. , 2013 .
[46] Thorsten Reemtsma,et al. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. , 2005, Water research.
[47] Werner Brack,et al. MODELKEY. Models for assessing and forecasting the impact of environmental key pollutants on freshwater and marine ecosystems and biodiversity (5 pp) , 2005, Environmental science and pollution research international.
[48] Manuela Pavan,et al. A set of case studies to illustrate the applicability of DART (Decision Analysis by Ranking Techniques) in the ranking of chemicals , 2008 .
[49] D. Barceló,et al. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). , 2010, Environment international.
[50] T. Ternes,et al. Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. , 2001, Journal of chromatography. A.
[51] Thomas Knacker,et al. Evaluation of Measured and Predicted Environmental Concentrations of Selected Human Pharmaceuticals and Personal Care Products (10 pp) , 2006, Environmental science and pollution research international.
[52] Anna-Karin Johansson,et al. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. , 2006, The Science of the total environment.
[53] Yaqi Cai,et al. Occurrence, distribution and bioaccumulation of antibiotics in the Haihe River in China. , 2012, Journal of environmental monitoring : JEM.
[54] A. Alves,et al. Amoxicillin degradation at ppb levels by Fenton's oxidation using design of experiments. , 2010, The Science of the total environment.